Abstract
Contact dermatitis describes the skin reaction resulting from exposure to irritants (irritant contact dermatitis) or allergens (allergic contact dermatitis). In most patients, irritant and allergic contact dermatitis (ACD) are clinically indistinguishable. Also histopathologically, no distinguishing markers have been identified. This is in line with the fact that in irritant and ACD, principal inflammatory pathways are essentially similar. The pivotal different factor in ACD is the involvement of “allergen-specific” T cells as initiators of the inflammatory skin reaction. In irritant contact dermatitis (ICD), the inflammatory reaction mainly depends on either or both chemical and physical irritation. The most frequent chemical irritative factors are long-lasting and repetitive contacts to water, detergents, solvents, or a combination of these factors, often aggravated by too high or too low humidity. Inflammatory reactions to irritants are not triggered by one specific substance or cause, and do not show rapid amplification of severity by repeated insults and are thus called “unspecific.”
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Elias PM (2005) Stratum corneum defensive functions: an integrated view. J Invest Dermatol 125:183–200
Elias PM (2007) The skin barrier as an innate immune element. Semin Immunopathol 29:3–14
Bouwstra JA, Ponec M (2006) The skin barrier in healthy and diseased state. Biochim Biophys Acta 1758:2080–2095
Elias PM (1983) Epidermal lipids, barrier function, and desquamation. J Invest Dermatol (80 suppl):44s–49s
Elias PM (2004) The epidermal permeability barrier: from the early days at Harvard to emerging concepts. J Invest Dermatol 122(2):xxxvi–xxxix
Hadgraft J, Lane ME (2005) Skin permeation: the years of enlightenment. Int J Pharm 305:2–12
Herkenne C, Alberti I, Naik A, Kalia YN, Mathy FX, Preat V, Guy RH (2008) In vivo methods for the assessment of topical drug bioavailability. Pharm Res 25:87–103
Moser K, Kriwet K, Naik A, Kalia YN, Guy RH (2001) Passive skin penetration enhancement and its quantification in vitro. Eur J Pharm Biopharm 52:103–112
Schaefer H, Lademann J (2001) The role of follicular penetration. A differential view. Skin Pharmacol Appl Skin Physiol (14 suppl 1):23–27
Basketter DA, Gerbrick F, Kimber I, Willis C (1999) Contact irritation mechanism. In: Toxicology of contact dermatitis. Wiley, Chichester
Enk AH, Katz SI (1992) Early events in the induction phase of contact sensitivity. J Invest Dermatol 99:39S–41S
Le TK, Schalkwijk J, van de Kerkhof PC, van HU, van der V (1998) A histological and immunohistochemical study on chronic irritant contact dermatitis. Am J Contact Dermatitis 9:23–28
Welss T, Basketter DA, Schroder KR (2004) In vitro skin irritation: facts and future. State of the art review of mechanisms and models. Toxicol In Vitro 18:231–243
Levin CY, Maibach HI (2002) Irritant contact dermatitis: is there an immunologic component? Int Immunopharmacol 2:183–189
Smith HR, Basketter DA, McFadden JP (2002) Irritant dermatitis, irritancy and its role in allergic contact dermatitis. Clin Exp Dermatol 27:138–146
Chew AL, Maibach HI (2003) Occupational issues of irritant contact dermatitis. Int Arch Occup Environ Health 76:339–346
English JS (2004) Current concepts of irritant contact dermatitis. Occup Environ Med 61(8):722–726, 674
Dickel H, Kuss O, Schmidt A, Kretz J, Diepgen TL (2002) Importance of irritant contact dermatitis in occupational skin disease. Am J Clin Dermatol 3:283–289
McDonald JC, Beck MH, Chen Y, Cherry NM (2006) Incidence by occupation and industry of work-related skin diseases in the United Kingdom, 1996-2001. Occup Med (Lond) 56:398–405
Diepgen TL, Coenraads PJ (1999) The epidemiology of occupational contact dermatitis. Int Arch Occup Environ Health 72:496–506
Bauer A, Bartsch R, Stadeler M, Schneider W, Grieshaber R, Wollina U, Gebhardt M (1998) Development of occupational skin diseases during vocational training in baker and confectioner apprentices: a follow-up study. Contact Dermatitis 39:307–311
Berndt U, Hinnen U, Iliev D, Elsner P (1999) Is occupational irritant contact dermatitis predictable by cutaneous bioengineering methods? Results of the Swiss Metalworker‘ Eczema Study (PROMETES). Dermatology 198:351–354
John SM, Uter W, Schwanitz HJ (2000) Relevance of multiparametric skin bioengineering in a prospectively-followed cohort of junior hairdressers. Contact Dermatitis 43:161–168
Koopman DG, Kezic S, Verberk MM (2004) Skin reaction and recovery: a repeated sodium lauryl sulphate patch test vs. a 24-h patch test and tape stripping. Br J Dermatol 150:493–499
Schmid K, Broding HC, Uter W, Drexler H (2005) Transepidermal water loss and incidence of hand dermatitis in a prospectively followed cohort of apprentice nurses. Contact Dermatitis 52:247–253
Smith HR, Armstrong DK, Holloway D, Whittam L, Basketter DA, McFadden JP (2002) Skin irritation thresholds in hairdressers: implications for the development of hand dermatitis. Br J Dermatol 146:849–852
Smith HR, Rowson M, Basketter DA, McFadden JP (2004) Intra-individual variation of irritant threshold and relationship to transepidermal water loss measurement of skin irritation. Contact Dermatitis 51:26–29
Coenraads PJ, Diepgen TL (1998) Risk for hand eczema in employees with past or present atopic dermatitis. Int Arch Occup Environ Health 71:7–13
Jakasa I, De Jongh CM, Verberk MM, Bos JD, Kezic S (2006) Percutaneous penetration of sodium lauryl sulphate is increased in uninvolved skin of patients with atopic dermatitis compared with control subjects. Br J Dermatol 155:104–109
De Jongh CM, John SM, Bruynzeel DP, Calkoen F, van Dijk FJ, Khrenova L, Rustemeyer T, Verberk MM, Kezic S (2008) Cytokine gene polymorphisms and susceptibility to chronic irritant contact dermatitis. Contact Dermatitis 58:269–277
De Jongh CM, Khrenova L, Kezic S, Rustemeyer T, Verberk MM, John SM (2008) Polymorphisms in the interleukin-1 gene influence the stratum corneum interleukin-1 alpha concentration in uninvolved skin of patients with chronic irritant contact dermatitis. Contact Dermatitis 58:263–268
De Jongh CM, Khrenova L, Verberk MM, Calkoen F, van Dijk FJ, Voss H, John SM, Kezic S (2008) Loss-of-function polymorphisms in the filaggrin gene are associated with an increased susceptibility to chronic irritant contact dermatitis: a case-control study. Br J Dermatol 159:621–627
Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, Goudie DR, Sandilands A, Campbell LE, Smith FJ, O’Regan GM, Watson RM, Cecil JE, Bale SJ, Compton JG, DiGiovanna JJ, Fleckman P, Lewis-Jones S, Arseculeratne G, Sergeant A, Munro CS, El HB, McElreavey K, Halkjaer LB, Bisgaard H, Mukhopadhyay S, McLean WH (2006) Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38:441–446
Sandilands A, Terron-Kwiatkowski A, Hull PR, O’Regan GM, Clayton TH, Watson RM, Carrick T, Evans AT, Liao H, Zhao Y, Campbell LE, Schmuth M, Gruber R, Janecke AR, Elias PM, van Steensel MA, Nagtzaam I, van GM, Steijlen PM, Munro CS, Bradley DG, Palmer CN, Smith FJ, McLean WH, Irvine AD (2007) Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet 39:650–654
Demehri S, Morimoto M, Holtzman MJ, Kopan R (2009) Skin-derived TSLP triggers progression from epidermal-barrier defects to asthma. PLoS Biol 7(5)
Marenholz I, Nickel R, Ruschendorf F, Schulz F, Esparza-Gordillo J, Kerscher T, Gruber C, Lau S, Worm M, Keil T, Kurek M, Zaluga E, Wahn U, Lee YA (2006) Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J Allergy Clin Immunol 118:866–871
Sandilands A, Sutherland C, Irvine AD, McLean WH (2009) Filaggrin in the frontline: role in skin barrier function and disease. J Cell Sci 122:1285–1294
Smith FJ, Irvine AD, Terron-Kwiatkowski A, Sandilands A, Campbell LE, Zhao Y, Liao H, Evans AT, Goudie DR, Lewis-Jones S, Arseculeratne G, Munro CS, Sergeant A, O’Regan G, Bale SJ, Compton JG, DiGiovanna JJ, Presland RB, Fleckman P, McLean WH (2006) Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat Genet 38:337–342
Stemmler S, Parwez Q, Petrasch-Parwez E, Epplen JT, Hoffjan S (2007) Two common loss-of-function mutations within the filaggrin gene predispose for early onset of atopic dermatitis. J Invest Dermatol 127:722–724
Hollegaard MV, Bidwell JL (2006) Cytokine gene polymorphism in human disease: on-line databases, Supplement 3. Genes Immun 7:269–276
Corsini E, Galli CL (2000) Epidermal cytokines in experimental contact dermatitis. Toxicology 142:203–211
Jacobs JJ, Lehe CL, Hasegawa H, Elliott GR, Das PK (2006) Skin irritants and contact sensitizers induce Langerhans cell migration and maturation at irritant concentration. Exp Dermatol 15:432–440
Williams IR, Kupper TS (1996) Immunity at the surface: homeostatic mechanisms of the skin immune system. Life Sci 58:1485–1507
Ouwehand K, Santegoets SJ, Bruynzeel DP, Scheper RJ, de Gruijl TD, Gibbs S (2008) CXCL12 is essential for migration of activated Langerhans cells from epidermis to dermis. Eur J Immunol 38:3050–3059
Spiekstra SW, Toebak MJ, Sampat-Sardjoepersad S, van Beek PJ, Boorsma DM, Stoof TJ, von Blomberg BM, Scheper RJ, Bruynzeel DP, Rustemeyer T, Gibbs S (2005) Induction of cytokine (interleukin-1alpha and tumor necrosis factor-alpha) and chemokine (CCL20, CCL27, and CXCL8) alarm signals after allergen and irritant exposure. Exp Dermatol 14:109–116
Effendy I, Loffler H, Maibach HI (2000) Epidermal cytokines in murine cutaneous irritant responses. J Appl Toxicol 20:335–341
Kupper TS (1990) Immune and inflammatory processes in cutaneous tissues. Mechanisms and speculations. J Clin Invest 86:1783–1789
McFadden JP, Basketter DA (2000) Contact allergy, irritancy and ‘danger’. Contact Dermatitis 42:123–127
Slodownik D, Lee A, Nixon R (2008) Irritant contact dermatitis: a review. Australas J Dermatol 49:1–9
De Jongh CM, Verberk MM, Spiekstra SW, Gibbs S, Kezic S (2007) Cytokines at different stratum corneum levels in normal and sodium lauryl sulphate-irritated skin. Skin Res Technol 13:390–398
Wood LC, Elias PM, Calhoun C, Tsai JC, Grunfeld C, Feingold KR (1996) Barrier disruption stimulates interleukin-1 alpha expression and release from a pre-formed pool in murine epidermis. J Invest Dermatol 106:397–403
De Jongh CM, Verberk MM, Withagen CE, Jacobs JJ, Rustemeyer T, Kezic S (2006) Stratum corneum cytokines and skin irritation response to sodium lauryl sulfate. Contact Dermatitis 54:325–333
Piguet PF, Grau GE, Hauser C, Vassalli P (1991) Tumor necrosis factor is a critical mediator in hapten induced irritant and contact hypersensitivity reactions. J Exp Med 173:673–679
Bergstresser PR (1989) Sensitization and elicitation of inflammation in contact dermatitis. In: Norris DA (ed) Immune mechanisms in cutaneous disease. Dekker, New York, pp 219–246
Turk JL (1975) Delayed hypersensitivity, 2nd edn. North-Holland, Amsterdam
Gell PDH, Coombs RRA, Lachman R (1975) Clinical aspects of immunology, 3rd edn. Blackwell, London
Mestas J, Hughes CC (2004) Of mice and not men: differences between mouse and human immunology. J Immunol 172:2731–2738
Saint-Mezard P, Krasteva M, Chavagnac C, Bosset S, Akiba H, Kehren J, Kanitakis J, Kaiserlian D, Nicolas JF, Berard F (2003) Afferent and efferent phases of allergic contact dermatitis (ACD) can be induced after a single skin contact with haptens: evidence using a mouse model of primary ACD. J Invest Dermatol 120:641–647
Bos JD, Meinardi MMHM (2000) The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol 9:165–169
Roberts DW, Lepoittevin J-P (1998) Allergic Contact Dermatitis. In: Lepoittevin J-P, Basketter DA, Goossens A, Karlberg A-T (eds). Springer, Berlin Heidelberg New York, pp 81–1118
Eliasson E, Kenna JG (1996) Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis. Mol Pharmacol 50:573–582
Budinger L, Hertl M (2000) Immunologic mechanisms in hypersensitivity reactions to metal ions: an overview. Allergy 55:108–115
Gerberick F, Aleksic M, Basketter D, Casati S, Karlberg AT, Kern P, Kimber I, Lepoittevin JP, Natsch A, Ovigne JM, Rovida C, Sakaguchi H, Schultz T (2008) Chemical reactivity measurement and the predicitve identification of skin sensitisers. The report and recommendations of ECVAM Workshop 64. Altern Lab Anim 36(2):215–242
Divkovic M, Pease CK, Gerberick GF, Basketter DA (2005) Hapten-protein binding: from theory to practical application in the in vitro prediction of skin sensitization. Contact Dermatitis 53(4):189–200
Mutschler J, Giménez-Arnau E, Foertsch L, Gerberick GF, Lepoittevin JP (2009) Mechanistic assessment of peptide reactivity assay to predict skin allergens with Kathon CG isothiazolinones. Toxicol In Vitro 23(3):439–446
Gerberick F, Aleksic M, Basketter D, Casati S, Karlberg AT, Kern P, Kimber I, Lepoittevin JP, Natsch A, Ovigne JM, Rovida C, Sakaguchi H, Schultz T (2008) Chemical reactivity measurement and the predicitve identification of skin sensitisers. The report and recommendations of ECVAM Workshop 64. Altern Lab Anim 36(2):215–242
Blauvelt A, Hwang ST, Udey MC (2003) Allergic and immunologic diseases of the skin. J Allergy Clin Immunol 111:S560–S570
Kimber I, Dearman RJ (2002) Allergic contact dermatitis: the cellular effectors. Contact Dermatitis 46:1–5
Liberato DJ, Byers VS, Ennick RG, Castagnoli N (1981) Region specific attack of nitrogen and sulfur nucleophiles on quinones from poison oak/ivy catechols (urushiols) and analogues as models for urushiol-protein conjugate formation. J Med Chem 24:28–33
Kalish RS, Wood JA, LaPorte A (1994) Processing of urushiol (poison ivy) hapten by both endogenous and exogenous pathways for presentation to T cells in vitro. J Clin Invest 93:2039–2047
Naisbitt DJ (2004) Drug hypersensitivity reactions in skin: understanding mechanisms and the development of diagnostic and predictive tests. Toxicology 194:179–196
Lepoittevin JP (2006) Metabolism versus chemical transformation or pro- versus prehaptens? Contact Dermatitis 54(2):73–74
Epling GA, Wells JL, Yoon UC (1988) Photochemical transformations in salicylanilide photoallergy. Photochem Photobiol 47:167–171
Krasteva M, Nicolas JF, Chabeau G, Garrigue JL, Bour H, Thivolet J, Schmitt D (1993) Dissociation of allergenic and immunogenic functions in contact sensitivity to para-phenylenediamine. Int Arch Allergy Immunol 102:200–204
Merk HF, Abel J, Baron JM, Krutmann J (2004) Molecular pathways in dermatotoxicology. Toxicol Appl Pharmacol 195:267–277
Schnuch A, Westphal GA, Muller MM, Schulz TG, Geier J, Brasch J, Merk HF, Kawakubo Y, Richter G, Koch P, Fuchs T, Gutgesell T, Reich K, Gebhardt M, Becker D, Grabbe J, Szliska C, Aberer W, Hallier E (1998) Genotype and phenotype of N-acetyltransferase 2 (NAT2) polymorphism in patients with contact allergy. Contact Dermatitis 38:209–211
Karlberg AT, Bergström MA, Börje A, Luthman K, Nilsson JL (2008) Allergic contact dermatitis–formation, structural requirements, and reactivity of skin sensitizers. Chem Res Toxicol 21(1):53–69
Patlewicz GY, Basketter DA, Pease CK, Wilson K, Wright ZM, Roberts DW, Bernard G, Arnau EG, Lepoittevin JP (2004) Further evaluation of quantitative structure–activity relationship models for the prediction of the skin sensitization potency of selected fragrance allergens. Contact Dermatitis 50:91–97
Langerhans P (1868) Über die Nerven der menschlichen Haut. Virchows Arch Pathol Anat 44:325–337
Wilson NS, Villadangos JA (2004) Lymphoid organ dendritic cells: beyond the Langerhans cells paradigm. Immunol Cell Biol 82:91–98
Hoath SB, Leahy DG (2003) The organization of human epidermis: functional epidermal units and phi proportionality. J Invest Dermatol 121:1440–1446
Breathnach SM (1988) The Langerhans cell. Centenary review. Br J Dermatol 119:463–469
Romani N, Holzmann S, Tripp CH, Koch F, Stoitzner P (2003) Langerhans cells – dendritic cells of the epidermis. APMIS 111:725–740
Kimber I, Dearman RJ (2003) What makes a chemical an allergen? Ann Allergy Asthma Immunol 90:28–31
Inaba K, Schuler G, Witmer MD, Valinsky J, Atassi B, Steinman RM (1986) Immunologic properties of purified epidermal Langerhans cells. Distinct requirements for stimulation of unprimed and sensitized T lymphocytes. J Exp Med 164:605–613
Kimber I, Cumberbatch M (1992) Dendritic cells and cutaneous immune responses to chemical allergens. Toxicol Appl Pharmacol 117:137–146
Seiffert K, Granstein RD (2006) Neuroendocrine regulation of skin dendritic cells. Ann N Y Acad Sci 1088(1):195–206
Dieu M-C, Vanbervliet B, Vicari A, Bridon J-M, Oldham E, Ait-Yahia S, Brière F, Zlotnik A, Lebecque S, Caux C (1998) Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 188:373–386
Stingl G, Katz SI, Clement L, Green I, Shevach EM (1978) Immunological functions of Ia-bearing epidermal Langerhans cells. J Immunol 121:2005–2013
Czernielewski SM, Demarchez M (1987) Further evidence for the self-reproducing capacity of Langerhans cells in human skin. J Invest Dermatol 88:17–20
Streilein JW, Grammer SF (1989) In vitro evidence that Langerhans cells can adopt two functionally distinct forms capable of antigen presentation to T lymphocytes. J Immunol 143:3925–3933
Birbeck M (1961) An electron microscope study of basal melanocytes and high level clear cells (Langerhans cells) in vitiligo. J Invest Dermatol 37:51–56
Braathen LR (1980) Studies on human epidermal Langerhans cells. III. Induction of T lymphocyte response to nickel sulphate in sensitized individuals. Br J Dermatol 103:517–526
Kimber I, Dearman RJ, Cumberbatch M, Huby RJ (1998) Langerhans cells and chemical allergy. Curr Opinion Immunol 10:614–619
Kimber I, Basketter DA, Gerberick GF, Dearman RJ (2002) Allergic contact dermatitis. Int Immunopharmacol 2:201–211
Park SH, Chiu YH, Jayawardena J, Roark J, Kavita U, Bendelac A (1998) Innate and adaptive functions of the CD1 pathway of antigen presentation. Semin Immunol 10:391–398
Weinlich G, Heine M, Stössel H, Zanella M, Stoitzner P, Ortner U, Smolle J, Koch F, Sepp NT, Schuler G, Romani N (1998) Entry into afferent lymphatics and maturation in situ of migrating murine cutaneous dendritic cells. J Invest Dermatol 110:441–448
Richters CD, Hoekstra MJ, van Baare J, Du Pont JS, Hoefsmit EC, Kamperdijk EW (1994) Isolation and characterization of migratory human skin dendritic cells. Clin Exp Immunol 98:330–336
Jakob T, Ring J, Udey MC (2001) Multistep navigation of Langerhans/dendritic cells in and out of the skin. J Allergy Clin Immunol 108:688–696
Ozawa H, Nakagawa S, Tagami H, Aiba S (1996) Interleukin-1b and granulocyte-macrophage colony stimulating factor mediate Langerhans cell maturation differently. J Invest Dermatol 106:441–445
Wong BR, Josien R, Lee SY, Sauter B, Li HL, Steinman RM, Choi YW (1997) TRANCE (Tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J Exp Med 186:2075–2080
Aiba S, Tagami H (1999) Dendritic cell activation induced by various stimuli, eg exposure to microorganisms, their products, cytokines, and simple chemicals as well as adhesion to extracellular matrix. J Dermatol Sci 20:1–13
Inaba K, Schuler G, Steinman RM (1993) GM-CSF – a granulocyte/macrophage/dendritic cell stimulating factor. In: Van Furth R (ed) Hemopoietic growth factors and mononuclear phagocytes. Karger, Basel, pp 187–196
Jakob T, Udey MC (1998) Regulation of E-Cadherin mediated adhesion in Langerhans cell-like dendritic cells by inflammatory mediators that mobilize Langerhans cells in vivo. J Immunol 160:4067–4073
Schwarzenberger K, Udey MC (1996) Contact allergens and epidermal proinflammatory cytokines modulate Langerhans cell E-cadherin expression in situ. J Invest Dermatol 106:553–558
Enk AH, Katz SI (1992) Early molecular events in the induction phase of contact sensitivity. Proc Natl Acad Sci U S A 89:1398–1402
Enk AH, Angeloni VL, Udey MC, Katz SI (1993) An essential role for Langerhans cell-derived IL-1b in the initiation of primary immune responses in skin. J Immunol 150:3698–3704
Iversen L, Johansen C (2008) Inflammasomes and inflammatory caspases in skin inflammation. Expert Rev Mol Diagn 8(6):697–705
Wang B, Esche C, Mamelak A, Freed I, Watanabe H, Sauder DN (2003) Cytokine knockouts in contact hypersensitivity research. Cytokine Growth Factor Rev 14:381–389
Tang A, Amagai M, Granger LG, Stanley JR, Udey MC (1993) Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature 361:82–85
Ma J, Wing J-H, Guo Y-J, Sy M-S, Bigby M (1994) In vivo treatment with anti-ICAM-1 and antiLFA-1 antibodies inhibits contact sensitization-induced migration of epidermal Langerhans cells to regional lymph nodes. Cell Immunol 158:389–399
Rambukhana A, Bos JD, Irik D, Menko WJ, Kapsenberg ML, Das PK (1995) In situ behaviour of human Langerhans cells in skin organ culture. Lab Invest 73:521–531
Price AA, Cumberbatch M, Kimber I (1997) α6 integrins are required for Langerhans cell migration from the epidermis. J Exp Med 186:1725–1735
Weiss JM, Sleeman J, Renkl AC, Dittmar H, Termeer CC, Taxis S, Howells N, Hofmann M, Kohler G, Schöpf E, Ponta H, Herrlich P, Simon JC (1997) An essential role for CD44 variant isoforms in epidermal Langerhans cell and blood dendritic cell function. J Cell Biol 137:1137–1147
Brand CU, Hunger RE, Yawalkar N, Gerber HA, Schaffner T, Braathen LR (1999) Characterization of human skin-derived CD1a-positive lymph cells. Arch Dermatol Res 291:65–72
Kobayashi Y (1997) Langerhans cells produce type IV collagenase (MMP-9) following epicutaneous stimulation with haptens. Immunology 90:496–501
Randolph GJ (2001) Dendritic cell migration to lymph nodes: cytokines, chemokines, and lipid mediators. Semin Immunol 13:267–274
Sallusto F, Lanzavecchia A, Mackay CR (1998) Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today 19:568–574
Zlotnik A, Morales J, Hedrick JA (1999) Recent advances in chemokines and chemokine receptors. Crit Rev Immunol 19:1–47
Caux C, Ait-Yahia S, Chemin K, de Bouteiller O, Dieu-Nosjean MC, Homey B, Massacrier C, Vanbervliet B, Zlotnik A, Vicari A (2000) Dendritic cell biology and regulation of dendritic cell trafficking by chemokines. Springer Semin Immunopathol 22:345–369
Sallusto F, Palermo B, Lenig D, Miettinen M, Matikainen S, Julkunen I, Forster R, Burgstahler R, Lipp M, Lanzavecchia A (1999) Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur J Immunol 29:1617–1625
Saeki H, Moore AM, Brown MJ, Hwan ST (1999) Secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J Immunol 162:2472–2475
Gunn MD, Tangemann K, Tam C, Cyster JG, Rosen SD, Williams LT (1998) A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naïve T lymphocytes. Proc Natl Acad Sci U S A 95:258–263
Kim CH, Broxmeyer HE (1999) Chemokines: signal lamps for trafficking of T and B cells for development and effector function. J Leuk Biol 65:6–15
Robbiani DF, Finch RA, Jager D, Muller WA, Sartorelli AC, Randolph GJ (2000) The leukotriene C(4) transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell 103:757–768
Honig SM, Fu S, Mao X, Yopp A, Gunn MD, Randolph GJ, Bromberg JS (2003) FTY720 stimulates multidrug transporter- and cysteinyl leukotriene-dependent T cell chemotaxis to lymph nodes. J Clin Invest 111:627–637
van de Ven R, Scheffer GL, Scheper RJ, de Gruijl TD (2009) The ABC of dendritic cell development and function. Trends Immunol 30(9):421–429
Sallusto F, Schaerli P, Loetscher P, Schaniel C, Lenig D, Mackay CR, Qin S, Lanzavecchia A (1998) Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol 28: 2760–2769
Cumberbatch M, Dearman RJ, Kimber I (1997) Interleukin 1-beta and the stimulation of Langerhans cell migration – comparisons with tumour necrosis factor alpha. Arch Dermatol Res 289:277–284
Heufler C, Koch F, Schuler G (1988) Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of epidermal Langerhans cells into potent immunostimulatory dendritic cells. J Exp Med 167:700–705
Steinman RM, Hoffman L, Pope M (1995) Maturation and migration of cutaneous dendritic cells. J Invest Dermatol 105:2S–7S
Furue M, Chang CH, Tamaki K (1996) Interleukin-1 but not tumor necrosis factor a synergistically upregulates the granulocyte-macrophage colony-stimulating factor-induced B7–1 expression of murine Langerhans cells. Br J Dermatol 135:194–198
Schuler G, Steinman RM (1985) Murine epidermal Langerhans cells mature into potent immune-stimulatory dendritic cells in vitro. J Exp Med 161:526–546
Haig DM, Hopkins J, Miller HRP (1999) Local immune responses in afferent and efferent lymph. Immunology 96:155–163
Altin JG, Sloan EK (1997) The role of CD45 and CD45-associated molecules in T cell activation. Immunol Cell Biol 75:430–445
Schon MP, Zollner TM, Boehncke WH (2003) The molecular basis of lymphocyte recruitment to the skin: clues for pathogenesis and selective therapies of inflammatory disorders. J Invest Dermatol 121:951–962
Von Andrian UH, Mrini C (1998) In situ analysis of lymphocyte migration to lymph nodes. Cell Adh Comm 6:85–96
Vestweber D, Blanks JE (1999) Mechanisms that regulate the function of the selectins and their ligands. Physiol Rev 79:181–213
Adema GJ, Hartgers F, Verstraten R, de Vries E, Marland G, Menon S, Foster J, Xu Y, Nooyen P, McClanahan T, Bacon KB, Figdor CG (1997) A dendritic-cell-derived C-C chemokine that preferentially attracts naïve T cells. Nature 387:713–717
Ngo VN, Tang LH, Cyster JG (1998) Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naïve T cells and activated B cells. J Exp Med 188:181–191
Nagira M, Imai T, Hieshima K, Kusuda J, Ridanpaa M, Takagi S, Nishimura M, Kakizaki M, Nomiyama H, Yoshie O (1997) Molecular cloning of a novel human CC chemokine secondary lymphoid-tissue chemokine that is a potent chemoattractant for lymphocytes and mapped to chromosome 9p13. J Biol Chem 272:19518–19524
Rustemeyer T, von Blomberg BME, de Ligter S, Frosch PJ, Scheper RJ (1999) Human T lymphocyte priming in vitro by dendritic cells. Clin Exp Immunol 117:209–216
Crivellato E, Vacca A, Ribatti D (2004) Setting the stage: an anatomist’s view of the immune system. Trends Immunol 25:210–217
Itano AA, Jenkins MK (2003) Antigen presentation to naive CD4 T cells in the lymph node. Nat Immunol 4:733–739
Griem P, Wulferink M, Sachs B, Gonzales JB, Gleichmann E (1998) Allergic and autoimmune reactions to xenobiotics: how do they arise? Immunol Today 19:133–141
Moulon C, Vollmer J, Weltzien H-U (1995) Characterization of processing requirements and metal crossreactivities in T cell clones from patients with allergic contact dermatitis to nickel. Eur J Immunol 25:3308–3315
Li QJ, Dinner AR, Qi S, Irvine DJ, Huppa JB, Davis MM, Chakraborty AK (2004) CD4 enhances T cell sensitivity to antigen by coordinating Lck accumulation at the immunological synapse. Nat Immunol 5:791–799
Schoenberger SP, Toes REM, Vandervoort EIH, Offringa R, Melief CJM (1998) T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480–483
Gascoigne NR, Zal T (2004) Molecular interactions at the T cell-antigen-presenting cell interface. Curr Opin Immunol 16:114–119
Cantrell D (1996) T cell receptor signal transduction pathways. Annu Rev Immunol 14:259–274
Kuo CT, Leiden JM (1999) Transcriptional regulation of T lymphocyte development and function. Annu Rev Immunol 17:149–187
Davis SJ, van der Merwe PA (2003) TCR triggering: co-receptor-dependent or -independent? Trends Immunol 24:624–626
Trautmann A, Randriamampita C (2003) Initiation of TCR signalling revisited. Trends Immunol 24:425–428
Acuto O, Michel F (2003) CD28-mediated co-stimulation: a quantitative support for TCR signalling. Nat Rev Immunol 3:939–951
Quezada SA, Jarvinen LZ, Lind EF, Noelle RJ (2004) CD40/CD154 interactions at the interface of tolerance and immunity. Annu Rev Immunol 22:307–328
Dong C, Nurieva RI, Prasad DV (2003) Immune regulation by novel costimulatory molecules. Immunol Res 28:39–48
Viola A, Lanzavecchia A (1996) T cell activation determined by T cell receptor number and tunable thresholds. Science 273:104–106
Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245–252
Hommel M (2004) On the dynamics of T-cell activation in lymph nodes. Immunol Cell Biol 82:62–66
Cella M, Sallusto F, Lanzavecchia A (1997) Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 9:10–16
Crispín JC, Tsokos GC (2009) Human TCR-alpha beta+ CD4- CD8- T cells can derive from CD8+ T cells and display an inflammatory effector phenotype. J Immunol 183(7):4675–4678
Malek TR, Yu A, Zhu L, Matsutani T, Adeegbe D, Bayer AL (2008) IL-2 family of cytokines in T regulatory cell development and homeostasis. J Clin Immunol 28(6):635–639
Pei Z, Lin D, Song X, Li H, Yao H (2008) TLR4 signaling promotes the expression of VEGF and TGFbeta1 in human prostate epithelial PC3 cells induced by lipopolysaccharide. Cell Immunol 254(1):20–27
Lan RY, Selmi C, Gershwin ME (2008) The regulatory, inflammatory, and T cell programming roles of interleukin-2 (IL-2). J Autoimmun 31(1):7–12
Dong C (2008) TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 8(5):337–348
Zhu J, Paul WE (2008) CD4 T cells: fates, functions, and faults. Blood 112(5):1557–1569
Sallusto F, Lanzavecchia A (2009) Human Th17 cells in infection and autoimmunity. Microbes Infect 11(5):620–624
Oboki K, Ohno T, Saito H, Nakae S (2008) Th17 and allergy. Allergol Int 57(2):121–134
Dabbagh K, Lewis DB (2003) Toll-like receptors and T-helper-1/T-helper-2 responses. Curr Opin Infect Dis 16:199–204
Faria AM, Weiner HL (2006) Oral tolerance and TGF-beta-producing cells. Inflamm Allergy Drug Targets 5(3):179–190
Korn T, Bettelli E, Oukka M, Kuchroo VK (2009) IL-17 and Th17 cells. Annu Rev Immunol 27:485–517. Review. PubMed PMID: 19132915
Louten J, Boniface K, de Waal Malefyt R (2009) Development and function of TH17 cells in health and disease. J Allergy Clin Immunol 123(5):1004–1011
Romagnani S (2006) Regulation of the T cell response. Clin Exp Allergy 36(11):1357–1366
Feuerer M, Hill JA, Mathis D, Benoist C (2009) Foxp3+ regulatory T cells: differentiation, specification, subphenotypes. Nat Immunol 10(7):689–695
Cavani A (2008) Immune regulatory mechanisms in allergic contact dermatitis and contact sensitization. Chem Immunol Allergy 94:93–100
Wu K, Bi Y, Sun K, Wang C (2007) IL-10-producing type 1 regulatory T cells and allergy. Cell Mol Immunol 4(4):269–275
Shevach EM (2009) Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 30(5):636–645
Basso AS, Cheroutre H, Mucida D (2009) More stories on Th17 cells. Cell Res 19(4):399–411
Zhou L, Littman DR (2009) Transcriptional regulatory networks in Th17 cell differentiation. Curr Opin Immunol 21(2):146–152. Review
Wilson CB, Rowell E, Sekimata M (2009) Epigenetic control of T-helper-cell differentiation. Nat Rev Immunol 9(2):91–105
Coulter EM, Jenkinson C, Farrell J, Lavergne SN, Pease C, White A, Aleksic M, Basketter D, Williams DP, King C, Pirmohamed M, Park BK, Naisbitt DJ (2010) Measurement of CD4+ and CD8+ T-lymphocyte cytokine secretion and gene expression changes in p-phenylenediamine allergic patients and tolerant individuals. J Invest Dermatol 130(1):161–174
Nakamura T, Lee RK, Nam SY, Podack ER, Bottomly K, Flavell RA (1997) Roles of IL-4 and IFN-g in stabilizing the T helper cell type-1 and 2 phenotype. J Immunol 158:2648–2653
Kang KF, Kubin M, Cooper KD, Lessin SR, Trinchieri G, Rook AH (1996) IL-12 synthesis by human Langerhans cells. J Immunol 156:1402–1407
Pulendran B (2004) Modulating TH1/TH2 responses with microbes, dendritic cells, and pathogen recognition receptors. Immunol Res 29:187–196
Kubo M, Ransom J, Webb D, Hashimoto Y, Tada T, Nakayama T (1997) T-cell subset-specific expression of the IL-4 gene is regulated by a silencer element and STAT6. EMBO J 16(13):4007–4020
Rogge L, Barberis-Maino L, Biffi M, Passini N, Presky DH, Gubler U, Sinigaglia F (1997) Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J Exp Med 185:825–831
Zhou L, Chong MM, Littman DR (2009) Plasticity of CD4+ T cell lineage differentiation. Immunity 30(5):646–655. Review. PubMed PMID: 19464987
Nakamura T, Kamogawa Y, Bottomly K, Flavell RA (1997) Polarization of IL-4- and IFN-gamma-producing CD4(+) T cells following activation of naive CD4(+) T cells. J Immunol 158:1085–1094
Orange JS, Biron CA (1996) An absolute and restricted requirement for IL-12 in natural killer cell IFN-g production and antiviral defense. J Immunol 156:1138–1142
Groux H, Sornasse T, Cottrez F, de Vries JE, Coffman RL, Roncarolo MG, Yssel H (1997) Induction of human T helper cell type-1 differentiation results in loss of IFN-g receptor b-chain expression. J Immunol 158:5627–5631
Gajewski TF, Fitch FW (1988) Antiproliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J Immunol 140:4245–4252
Takatori H, Kanno Y, Chen Z, O’Shea JJ (2008) New complexities in helper T cell fate determination and the implications for autoimmune diseases. Mod Rheumatol 18(6):533–541
Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G (1996) Ligation of CD40 on dendritic cells triggers production of high levels of interleukin 12 and enhances T cell stimulatory capacity. J Exp Med 184:747–752
Ohshima Y, Tanaka Y, Tozawa H, Takahashi Y, Maliszewski C, Delespesse C (1997) Expression and function of OX40 ligand on human dendritic cells. J Immunol 159:3838–3848
Croft M (2009) The role of TNF superfamily members in T-cell function and diseases. Nat Rev Immunol 9(4):271–278
Iliev ID, Mileti E, Matteoli G, Chieppa M, Rescigno M (2009) Intestinal epithelial cells promote colitis-protective regulatory T-cell differentiation through dendritic cell conditioning. Mucosal Immunol 2(4):340–350
Izcue A, Coombes JL, Powrie F (2009) Regulatory lymphocytes and intestinal inflammation. Annu Rev Immunol 27:313–338
Hoyer KK, Dooms H, Barron L, Abbas AK (2008) Interleukin-2 in the development and control of inflammatory disease. Immunol Rev 226:19–28
Létourneau S, Krieg C, Pantaleo G, Boyman O (2009) IL-2- and CD25-dependent immunoregulatory mechanisms in the homeostasis of T-cell subsets. J Allergy Clin Immunol 123(4):758–762
Oukka M (2008) Th17 cells in immunity and autoimmunity. Ann Rheum Dis 67(suppl 3):iii26–iii29
Larsen JM, Bonefeld CM, Poulsen SS, Geisler C, Skov L (2009) IL-23 and T(H)17-mediated inflammation in human allergic contact dermatitis. J Allergy Clin Immunol 123(2):486–492
Edele F, Esser PR, Lass C, Laszczyk MN, Oswald E, Strüh CM, Rensing-Ehl A, Martin SF (2007) Innate and adaptive immune responses in allergic contact dermatitis and autoimmune skin diseases. Inflamm Allergy Drug Targets 6(4):236–244
Fyhrquist-Vanni N, Alenius H, Lauerma A (2007) Contact dermatitis. Dermatol Clin 25(4):613–623
Werfel T, Hentschel M, Kapp A, Renz H (1997) Dichotomy of blood- and skin-derived IL-4-producing allergen-specific T cells and restricted V beta repertoire in nickel-mediated contact dermatitis. J Immunol 158:2500–2505
Probst P, Küntzlin D, Fleischer B (1995) TH2-type infiltrating T cells in nickel-induced contact dermatitis. Cell Immunol 165:134–140
Grewe M, Bruijnzeel-Koomen CA, Schöpf E, Thepen T, Langeveld-Wildschut AG, Ruzicka T, Krutmann J (1998) A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 19(8):359–361
Perez VL, Lederer JA, Lichtman AH, Abbas AK (1995) Stability of Th1 and Th2 populations. Int Immunol 7:869–875
Ulrich P, Grenet O, Bluemel J, Vohr HW, Wiemann C, Grundler O, Suter W (2001) Cytokine expression profiles during murine contact allergy: T helper 2 cytokines are expressed irrespective of the type of contact allergen. Arch Toxicol 75(8):470–479
van Beelen AJ, Teunissen MB, Kapsenberg ML, de Jong EC (2007) Interleukin-17 in inflammatory skin disorders. Curr Opin Allergy Clin Immunol 7(5):374–381
Mucida D, Salek-Ardakani S (2009) Regulation of TH17 cells in the mucosal surfaces. J Allergy Clin Immunol 123(5):997–1003
Constant SL, Bottomly K (1997) Induction of Th1 and Th2 CD4+ T cell responses: the alternate approaches. Annu Rev Immunol 15:297–322
Constant SL, Pfeiffer C, Woodard A, Pasqualini T, Bottomly K (1995) Extent of T cell receptor ligation can determine the functional differentiation of naïve CD4+ T cells. J Exp Med 5:1591–1596
Bretscher PA, Ogunremi O, Menon JN (1997) Distinct immunological states in murine cutaneous leishmaniasis by immunizing with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states. Behring Inst Mitt 98: 153–159
Toebak MJ, Moed H, von Blomberg MB, Bruynzeel DP, Gibbs S, Scheper RJ, Rustemeyer T (2006) Intrinsic characteristics of contact and respiratory allergens influence production of polarizing cytokines by dendritic cells. Contact Dermatitis 55(4):238–245
Watanabe H, Gehrke S, Contassot E, Roques S, Tschopp J, Friedmann PS, French LE, Gaide O (2008) Danger signaling through the inflammasome acts as a master switch between tolerance and sensitization. J Immunol 180(9):5826–5832
Kanerva L, Hyry H, Jolanki R, Hytonen M, Estlander T (1997) Delayed and immediate allergy caused by methylhexahydrophthalic anhydride. Contact Dermatitis 36:34–38
Geenen V, Brilot F (2003) Role of the thymus in the development of tolerance and autoimmunity towards the neuroendocrine system. Ann N Y Acad Sci 992:186–195
Luger TA, Lotti T (1998) Neuropeptides: role in inflammatory skin diseases. J Eur Acad Derm Venereol 10:207–211
Luger TA (2002) Neuromediators – a crucial component of the skin immune system. J Dermatol Sci 30(2):87–93
Lord GM, Matarese G, Howard LK, Baker RJ, Bloom SR, Lechler RI (1998) Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394:897–901
Morfin R, Lafaye P, Cotillon AC, Nato F, Chmielewski V, Pompon D (2000) 7 alpha-hydroxy-dehydroepiandrosterone and immune response. Ann N Y Acad Sci 917: 971–982
Cutolo M, Seriolo B, Villaggio B, Pizzorni C, Craviotto C, Sulli A (2002) Androgens and estrogens modulate the immune and inflammatory responses in rheumatoid arthritis. Ann N Y Acad Sci 966:131–142
Kidd P (2003) Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev 8:223–246
Piccinni MP, Giudizi MG, Biagiotti R, Beloni L, Giannarini L, Sampognaro S, Parronchi P, Manetti R, Annuziato F, Livi C, Romagnani S, Maggi E (1995) Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J Immunol 155:128–133
Vieira PL, Kalinski P, Wierenga EA, Kapsenberg ML, Dejong EC (1998) Glucocorticoids inhibit bioactive IL-12P70 production by in vitro-generated human dendritic cells without affecting their T cell stimulatory potential. J Immunol 161:5245–5251
Calder PC, Bevan SJ, Newsholme EA (1992) The inhibition of T-lymphocyte proliferation by fatty acids is via an eicosanoid-independent mechanism. Immunology 75: 108–115
Uotila P (1996) The role of cyclic AMP and oxygen intermediates in the inhibition of cellular immunity in cancer. Cancer Immunol Immunother 43:1–9
Demeure CE, Yang LP, Desjardins C, Raynauld P, Delespesse G (1997) Prostaglandin E-2 primes naïve T cells for the production of anti-inflammatory cytokines. Eur J Immunol 27:3526–3531
Abe N, Katamura K, Shintaku N, Fukui T, Kiyomasu T, Lio J, Ueno H, Tai G, Mayumi M, Furusho K (1997) Prostaglandin E2 and IL-4 provide naïve CD4+ T cells with distinct inhibitory signals for the priming of IFN-gamma production. Cell Immunol 181:86–92
Kalinski P, Hilkens CMU, Snijders A, Snijdewint FGM, Kapsenberg ML (1997) IL-12 deficient dendritic cells, generated in the presence of prostaglandin E2, promote type-2 cytokine production in maturing human naïve T helper cells. J Immunol 159:28–35
Edele F, Molenaar R, Gütle D, Dudda JC, Jakob T, Homey B, Mebius R, Hornef M, Martin SF (2008) Cutting edge: instructive role of peripheral tissue cells in the imprinting of T cell homing receptor patterns. J Immunol 181(6):3745–3749
Woodland DL, Kohlmeier JE (2009) Migration, maintenance and recall of memory T cells in peripheral tissues. Nat Rev Immunol 9(3):153–156
Fuhlbrigge RC, Kieffer JD, Armerding D, Kupper TS (1997) Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells. Nature 389:978–981
Sigmundsdottir H, Butcher EC (2008) Environmental cues, dendritic cells and the programming of tissue-selective lymphocyte trafficking. Nat Immunol 9(9):981–987
Miles A, Liaskou E, Eksteen B, Lalor PF, Adams DH (2008) CCL25 and CCL28 promote alpha4 beta7-integrin-dependent adhesion of lymphocytes to MAdCAM-1 under shear flow. Am J Physiol Gastrointest Liver Physiol 294(5):G1257–G1267
Sallusto F, Geginat J, Lanzavecchia A (2004) Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 22:745–763
Sallusto F, Lenig D, Förster R, Lipp M, Lanzavecchia A (1999) Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401(6754):708–712
Austrup F, Vestweber D, Borges E, Lohning M, Brauer R, Herz U, Renz H, Hallmann R, Scheffold A, Radbruch A, Hamann A (1997) P- and E selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues. Nature 385:81–83
Duhen T, Geiger R, Jarrossay D, Lanzavecchia A, Sallusto F (2009) Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol 10(8):857–863
Borges E, Tietz W, Steegmaier M, Moll T, Hallmann R, Hamann A, Vestweber D (1997) P-selectin glycoprotein ligand-1 (PSGL-1) on T helper 1 but not on T helper 2 cells binds to P-selectin and supports migration into inflamed skin. J Exp Med 185:573–578
Ward SG, Marelli-Berg FM (2009) Mechanisms of chemokine and antigen-dependent T-lymphocyte navigation. Biochem J 418(1):13–27
Hudak S, Hagen M, Liu Y, Catron D, Oldham E, McEvoy LM, Bowman EP (2002) Immune surveillance and effector functions of CCR10(+) skin homing T cells. J Immunol 169(3):1189–1196
Kitagaki H, Ono N, Hayakawa K, Kitazawa T, Watanabe K, Shiohara T (1997) Repeated elicitation of contact hypersensitivity induces a shift in cutaneous cytokine milieu from a T helper cell type 1 to a T helper cell type 2 profile. J Immunol 159(5):2484–2491
Cavani A, Mei D, Guerra E, Corinti S, Giani M, Pirrotta L, Puddu P, Girolomoni G (1998) Patients with allergic contact dermatitis to nickel and nonallergic individuals display different nickel-specific T cell responses. Evidence for the presence of effector CD8+ and regulatory CD4+ T cells. J Invest Dermatol 111:621–628
Lindemann M, Rietschel F, Zabel M, Grosse-Wilde H (2008) Detection of chromium allergy by cellular in vitro methods. Clin Exp Allergy 38(9):1468–1475
Kalish RS (1990) The use of human T-lymphocyte clones to study T-cell function in allergic contact dermatitis to urushiol. J Invest Dermatol 94(6 suppl):108S–111S
von Blomberg BME, Bruynzeel DP, Scheper RJ (1991) Advances in mechanisms ofallergic contact dermatitis: in vitro and in vivo research. In: Marzulli FN, Maibach HI (eds) Dermatotoxicology, 4th edn. Hemisphere Publishing Corporation, New York, pp 255–362
Bordignon V, Palamara F, Cordiali-Fei P, Vento A, Aiello A, Picardo M, Ensoli F, Cristaudo A (2008) Nickel, palladium and rhodium induced IFN-gamma and IL-10 production as assessed by in vitro ELISpot-analysis in contact dermatitis patients. BMC Immunol 9:19
Minang JT, Troye-Blomberg M, Lundeberg L, Ahlborg N (2005) Nickel elicits concomitant and correlated in vitro production of Th1-, Th2-type and regulatory cytokines in subjects with contact allergy to nickel. Scand J Immunol 62(3):289–296
Moed H, von Blomberg BM, Bruynzeel DP, Scheper RJ, Gibbs S, Rustemeyer T (2005) Regulation of nickel-induced T-cell responsiveness by CD4+CD25+ cells in contact allergic patients and healthy individuals. Contact Dermatitis 53(2):71–74
Rustemeyer T, von Blomberg BME, van Hoogstraten IMW, Bruynzeel DP, Scheper RJ (2004) Analysis of effector and regulatory immune-reactivity to nickel. Clin Exp Allergy 34(9):1458–1466
Spiewak R, Moed H, von Blomberg BM, Bruynzeel DP, Scheper RJ, Gibbs S, Rustemeyer T (2007) Allergic contact dermatitis to nickel: modified in vitro test protocols for better detection of allergen-specific response. Contact Dermatitis 56(2):63–69
Minang JT, Areström I, Ahlborg N (2008) ELISpot displays a better detection over ELISA of T helper (Th) 2-type cytokine-production by ex vivo-stimulated antigen-specific T cells from human peripheral blood. Immunol Invest 37(4):279–291
Minang JT, Areström I, Troye-Blomberg M, Lundeberg L, Ahlborg N (2006) Nickel, cobalt, chromium, palladium and gold induce a mixed Th1- and Th2-type cytokine response in vitro in subjects with contact allergy to the respective metals. Clin Exp Immunol 146(3):417–426
Wahlkvist H, Masjedi K, Gruvberger B, Zuber B, Karlberg AT, Bruze M, Ahlborg N (2008) The lipophilic hapten parthenolide induces interferon-gamma and interleukin-13 production by peripheral blood-derived CD8+ T cells from contact allergic subjects in vitro. Br J Dermatol 158(1):70–77
Skazik C, Grannemann S, Wilbers L, Merk HF, Coenraads PJ, Breuer S, Blömeke B (2008) Reactivity of in vitro activated human T lymphocytes to p-phenylenediamine and related substances. Contact Dermatitis 59(4):203–211
Boyman O, Létourneau S, Krieg C, Sprent J (2009) Homeostatic proliferation and survival of naïve and memory T cells. Eur J Immunol 39(8):2088–2094
Rustemeyer T, von Blomberg BME, de Ligter S, Frosch PJ, Scheper RJ (1999) Human T lymphocyte priming in vitro by haptenated autologous dendritic cells. Clin Exp Immunol 117:209–216
Goebeler M, Meinardus-Hager G, Roth J, Goerdt S, Sorg C (1993) Nickel chloride and cobalt chloride, two common contact sensitizers, directly induce expression of intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and endothelial leukocyte adhesion molecule (ELAM-1) by endothelial cells. J Invest Dermatol 100:759–765
Goebeler M, Roth J, Brocker EB, Sorg C, Schulze-Osthoff K (1995) Activation of nuclear factor-kappa B and gene expression in human endothelial cells by the common haptens nickel and cobalt. J Immunol 155:2459–2467
Walsh LJ, Lavker RM, Murphy GF (1990) Determinants of immune cell trafficking in the skin. Lab Invest 63: 592–600
Waldorf HA, Walsh LJ, Schechter NM, Murphy GF (1991) Early molecular events in evolving cutaneous delayed hypersensitivity in humans. Am J Pathol 138:477–486
Meller S, Lauerma AI, Kopp FM, Winterberg F, Anthoni M, Müller A, Gombert M, Haahtela A, Alenius H, Rieker J, Dieu-Nosjean MC, Kubitza RC, Gleichmann E, Ruzicka T, Zlotnik A, Homey B (2007) Chemokine responses distinguish chemical-induced allergic from irritant skin inflammation: memory T cells make the difference. J Allergy Clin Immunol 119(6):1470–1480
Bangert C, Friedl J, Stary G, Stingl G, Kopp T (2003) Immunopathologic features of allergic contact dermatitis in humans: participation of plasmacytoid dendritic cells in the pathogenesis of the disease? J Invest Dermatol 121: 1409–1418
Houck G, Saeed S, Stevens GL, Morgan MB (2004) Eczema and the spongiotic dermatoses: a histologic and pathogenic update. Semin Cutan Med Surg 23:39–45
Silberberg-Sinakin I, Thorbecke GJ, Baer RL, Rosenthal SA, Berezowsky V (1976) Antigen-bearing Langerhans cells in skin, dermal lymphatics, and in lymph nodes. Cell Immunol 25:137–151
Hill S, Edwards AJ, Kimber I, Knight SC (1990) Systemic migration of dendritic cells during contact sensitization. Immunology 71:277–281
Toebak MJ, Gibbs S, Bruynzeel DP, Scheper RJ, Rustemeyer T (2009) Dendritic cells: biology of the skin. Contact Dermatitis 60(1):2–20
Sterry W, Künne N, Weber-Matthiesen K, Brasch J, Mielke V (1991) Cell trafficking in positive and negative patch test reactions: demonstration of a stereotypic migration pathway. J Invest Dermatol 96:459–462
Herzog WR, Meade R, Pettinicchi A, Ptak W, Askenase PW (1989) Nude mice produce a T cell-derived antigen-binding factor that mediates the early component of delayed-type hypersensitivity. J Immunol 142:1803–1812
Willis CM, Young E, Brandon DR, Wilkinson JD (1986) Immunopathological and ultrastructural findings in human allergic and irritant contact dermatitis. Br J Dermatol 115:305–316
Brasch J, Burgard J, Sterry W (1992) Common pathways in allergic and irritant contact dermatitis. J Invest Dermatol 98:166–170
Hoefakker S, Caubo M, van ‘t Herve EHM, Roggeveen MJ, Boersma WJA, van Joost TH, Notten WRF, Claassen E (1995) In vivo cytokine profiles in allergic and irritant contact dermatitis. Contact Dermatitis 33:258–266
Flier J, Boorsma DM, Bruynzeel DP, van Beek PJ, Stoof TJ, Scheper RJ, Willemze R, Tensen CP (1999) The CXCR3 activating chemokines IP-10, MIG and IP-9 are expressed in allergic but not in irritant patch test reactions. J Invest Dermatol 113:574–578
Kondo S, Sauder DN (1995) Epidermal cytokines in allergic contact dermatitis. J Am Acad Dermatol 33:786–800
Wardorf HA, Walsh LJ, Schechter NM (1991) Early cellular events in evolving cutaneous delayed hypersensitivity in humans. Am J Pathol 138:477–486
Pober JS, Bevilacqua MP, Mendrick DL, Lapierre LA, Fiers W, Gimbrone MA Jr (1986) Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells. J Immunol 136:1680–1687
Shimizu Y, Newman W, Gopal TV, Horgan KJ, Graber N, Beall LD, van Seventer GA, Shaw S (1991) Four molecular pathways of T cell adhesion to endothelial cells: roles of LFA-1, VCAM-1, and ELAM-1 and changes in pathway hierarchy under different activation conditions. J Cell Biol 113:1203–1212
Ross R, Gilitzer C, Kleinz R, Schwing J, Kleinert H, Forstermann U, Reske-Kunz AB (1998) Involvement of NO in contact hypersensitivity. Int Immunol 10:61–69
Rowe A, Farrell AM, Bunker CB (1997) Constitutive endothelial and inducible nitric oxide synthase in inflammatory dermatoses. Br J Dermatol 136:18–23
Szepietowski JC, McKenzie RC, Keohane SG, Walker C, Aldridge RD, Hunter JA (1997) Leukaemia inhibitory factor: induction in the early phase of allergic contact dermatitis. Contact Dermatitis 36:21–25
Yu X, Barnhill RL, Graves DT (1994) Expression of monocyte chemoattractant protein-1 in delayed type hypersensitivity reactions in the skin. Lab Invest 71:226–235
Buchanan KL, Murphy JW (1997) Kinetics of cellular infiltration and cytokine production during the efferent phase of a delayed-type hypersensitivity reaction. Immunology 90:189–197
Kish DD, Li X, Fairchild RL (2009) CD8 T cells producing IL-17 and IFN-gamma initiate the innate immune response required for responses to antigen skin challenge. J Immunol 182(10):5949–5959
Toebak MJ, Pohlmann PR, Sampat-Sardjoepersad SC, von Blomberg BM, Bruynzeel DP, Scheper RJ, Rustemeyer T, Gibbs S (2006) CXCL8 secretion by dendritic cells predicts contact allergens from irritants. Toxicol In Vitro 20(1):117–124
Askenase PW, Kawikova I, Paliwal V, Akahira-Azuma M, Gerard C, Hugli T, Tsuji R (1999) A new paradigm of T cell allergy: requirement for the B-1 cell subset. Int Arch Allergy Immunol 118(2–4):145–149
Van Loweren H, Meade R, Askenase PW (1983) An early component of delayed type hypersensitivity mediated by T cells and mast cells. J Exp Med 157:1604–1617
Foreman KE, Vaporciyan AA, Bonish BK, Jones ML, Johnson KJ, Glovsky MM, Eddy SM, Ward PA (1994) C5a-induced expression of P-selectin in endothelial cells. J Clin Invest 94:1147–1155
Groves RW, Allen MH, Ross EL, Barker JN, MacDonald DM (1995) Tumor necrosis factor alpha is pro-inflammatory in normal human skin and modulates cutaneous adhesion molecule expression. Br J Dermatol 132:345–352
Tsuji RF, Geba GP, Wang Y, Kawamoto K, Matis LA, Askenase PW (1997) Required early complement activation in contact sensitivity with generation of local C5-dependent chemotactic activity, and late T cell interferon g: a possible initiating role of B cells. J Exp Med 186:1015–1026
Nataf S, Davoust N, Ames RS, Barnum SR (1999) Human T cells express the C5a receptor and are chemoattracted to C5a. J Immunol 162:4018–4023
Wilkinson SM, Mattey DL, Beck MH (1994) IgG antibodies and early intradermal reactions to hydrocortisone in patients with cutaneous delayed-type hypersensitivity to hydrocortisone. Br J Dermatol 131:495–498
Shirakawa T, Kusaka Y, Morimoto K (1992) Specific IgE antibodies to nickel in workers with known reactivity to cobalt. Clin Exp Allergy 22:213–218
Redegeld FA, Nijkamp FP (2003) Immunoglobulin free light chains and mast cells: pivotal role in T-cell-mediated immune reactions? Trends Immunol 24:181–185
O’Leary JG, Goodarzi M, Drayton DL, von Andrian UH (2006) T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol 7(5): 507–516
Nieuwenhuis P, Ford WL (1976) Comparative migration of B- and T-Lymphocytes in the rat spleen and lymph nodes. Cell Immunol 23(2):254–267
Gober MD, Fishelevich R, Zhao Y, Unutmaz D, Gaspari AA (2008) Human natural killer T cells infiltrate into the skin at elicitation sites of allergic contact dermatitis. J Invest Dermatol 128(6):1460–1469
Dieli F, Ptak W, Sireci G, Romano GC, Potestio M, Salerno A, Asherson GL (1998) Cross-talk between V-beta-8(+) and gamma-delta(+) T lymphocytes in contact sensitivity. Immunology 93:469–477
Milon G, Marchal G, Seman M, Truffa-Bachi P (1981) A delayed-type hypersensitivity reaction initiated by a single T lymphocyte. Agents Actions 11:612–614
Marchal G, Seman M, Milon G, Truffa-Bachi P, Zilberfarb V (1982) Local adoptive transfer of skin delayed-type hypersensitivity initiated by a single T lymphocyte. J Immunol 129:954–958
Scheper RJ, van Dinther-Janssen AC, Polak L (1985) Specific accumulation of hapten-reactive T cells in contact sensitivity reaction sites. J Immunol 134:1333–1336
Macatonia SE, Knight SC, Edwards AJ, Griffiths S, Fryer P (1987) Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies. J Exp Med 166:1654–1667
Lappin MB, Kimber I, Norval M (1996) The role of dendritic cells in cutaneous immunity. Arch Dermatol Res 288:109–121
Moed H, Boorsma DM, Stoof TJ, von Blomberg BM, Bruynzeel DP, Scheper RJ, Gibbs S, Rustemeyer T (2004) Nickel-responding T cells are CD4+ CLA+ CD45RO+ and express chemokine receptors CXCR3, CCR4 and CCR10. Br J Dermatol 151:32–41
Vocanson M, Hennino A, Cluzel-Tailhardat M, Saint-Mezard P, Benetiere J, Chavagnac C, Berard F, Kaiserlian D, Nicolas JF (2006) CD8+ T cells are effector cells of contact dermatitis to common skin allergens in mice. J Invest Dermatol 126(4):815–820
Abe M, Kondo T, Xu H, Fairchild RL (1996) Interferon-gamma inducible protein (IP-10) expression is mediated by CD8+ T cells and is regulated by CD4+ T cells during the elicitation of contact hypersensitivity. J Invest Dermatol 107:360–366
Saulnier M, Huang S, Aguet M, Ryffel B (1995) Role of interferon-gamma in contact hypersensitivity assessed in interferon-gamma receptor-deficient mice. Toxicology 102(3):301–312
Rowe A, Bunker CB (1998) Interleukin-4 and the interleukin-4 receptor in allergic contact dermatitis. Contact Dermatitis 38:36–39
Asherson GL, Dieli F, Sireci G, Salerno A (1996) Role of IL-4 in delayed type hypersensitivity. Clin Exp Immunol 103:1–4
Asada H, Linton J, Katz SI (1997) Cytokine gene expression during the elicitation phase of contact sensitivity – regulation by endogenous IL-4. J Invest Dermatol 108:406–411
Kitagaki H, Fujisawa S, Watanabe K, Hayakawa K, Shiohara T (1995) Immediate-type hypersensitivity response followed by late reaction is induced by repeated epicutaneous application of contact sensitizing agents in mice. J Invest Dermatol 105:749–755
Carroll JM, Crompton T, Seery JP, Watt FM (1997) Transgenic mice expressing IFN-gamma in the epidermis have eczema, hair hypopigmentation, and hair loss. J Invest Dermatol 108:412–422
Lider O, Cahalon L, Gilat D, Hershkoviz R, Siegel D, Margalit R, Shoseyov O, Cohen IR (1995) A disaccharide that inhibits tumor necrosis factor alpha is formed from the extracellular matrix by the enzyme heparinase. Proc Natl Acad Sci U S A 92:5037–5041
Kothny-Wilkes G, Kulms D, Poppelmann B, Luger TA, Kubin M, Schwarz T (1998) Interleukin-1 protects transformed keratinocytes from tumor necrosis factor-related apoptosis-inducing ligand. J Biol Chem 273:29247–29253
Orteu CH, Poulter LW, Rustin MHA, Sabin CA, Salmon M, Akbar AN (1998) The role of apoptosis in the resolution of T cell-mediated cutaneous inflammation. J Immunol 161:1619–1629
Zhang X, Brunner T, Carter L, Dutton RW, Rogers P, Bradley L, Sato T, Reed JC, Green D, Swain SL (1997) Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis. J Exp Med 185:1837–1849
Enk AH, Katz SI (1992) Identification and induction of keratinocyte-derived IL-10. J Immunol 149:92–95
Schwarz A, Grabbe S, Riemann H, Aragane Y, Simon M, Manon S, Andrade S, Luger TA, Zlotnik A, Schwarz T (1994) In vivo effects of interleukin-10 on contact hypersensitivity and delayed-type hypersensitivity reactions. J Invest Dermatol 103:211–216
Berg DJ, Leach MW, Kuhn R, Rajewsky K, Muller W, Davidson NJ, Rennick D (1995) Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses. J Exp Med 182:99–108
Morel PA, Oriss TB (1998) Crossregulation between Th1 and Th2 cells. Crit Rev Immunol 18:275–303
Lalani I, Bhol K, Ahmed AR (1997) Interleukin-10 biology, role in inflammation and autoimmunity. Ann Allergy Asthma Immunol 79:469–484
Epstein SP, Baer RL, Thorbecke GJ, Belsito DV (1991) Immunosuppressive effects of transforming growth factor beta: inhibition of the induction of Ia antigen on Langerhans cells by cytokines and of the contact hypersensitivity response. J Invest Dermatol 96:832–837
Lawrence JN, Dickson FM, Benford DJ (1997) Skin irritant-induced cytotoxicity and prostaglandin E-2 release in human skin keratinocyte cultures. Toxicol Vitro 11:627–631
Walker C, Kristensen F, Bettens F, deWeck AL (1983) Lymphokine regulation of activated (G1) lymphocytes. I. Prostaglandin E2-induced inhibition of interleukin 2 production. J Immunol 130:1770–1773
Weston MC, Peachell PT (1998) Regulation of human mast cell and basophil function by cAMP. Gen Pharmacol 31:715–719
Dvorak HF, Mihm MC Jr, Dvorak AM (1976) Morphology of delayed-type hypersensitivity reactions in man. J Invest Dermatol 64:391–401
Marone G, Spadaro G, Patella V, Genovese A (1994) The clinical relevance of basophil releasability. J Aller Clin Immunol 94:1293–1303
Lundeberg L, Mutt V, Nordlind K (1999) Inhibitory effect of vasoactive intestinal peptide on the challenge phase of allergic contact dermatitis in humans. Acta Derm Venereol 79:178–182
Boerrigter GH, Scheper RJ (1987) Local and systemic desensitization induced by repeated epicutaneous hapten application. J Invest Dermatol 88:3–7
Jensen CS, Menne T, Lisby S, Kristiansen J, Veien NK (2003) Experimental systemic contact dermatitis from nickel: a dose-response study. Contact Dermatitis 49:124–132
Hindsen M, Bruze M, Christensen OB (2001) Flare-up reactions after oral challenge with nickel in relation to challenge dose and intensity and time of previous patch test reactions. J Am Acad Dermatol 44:616–623
Larsson A, Moller H, Björkner B, Bruze M (1997) Morphology of endogenous flare-up reactions in contact allergy to gold. Acta Derm Venereol 77:474–479
Skog E (1976) Spontaneous flare-up reactions induced by different amounts of 1, 3-dinitro-4-chlorobenzene. Acta Derm Venereol 46:386–395
Scheper RJ, von Blomberg BME, Boerrigter GH, Bruynzeel D, van Dinther A, Vos A (1983) Induction of local memory in the skin. Role of local T cell retention. Clin Exp Immunol 51:141–148
Moed H, Boorsma DM, Tensen CP, Flier J, Jonker MJ, Stoof TJ, Von Blomberg BM, Bruynzeel DP, Scheper RJ, Rustemeyer T, Gibbs S (2004) Increased CCL27-CCR10 expression in allergic contact dermatitis: implications for local skin memory. J Pathol 204:39–46
Christensen OB, Beckstead JH, Daniels TE, Maibach HI (1985) Pathogenesis of orally induced flare-up reactions at old patch sites in nickel allergy. Acta Derm Venereol 65:298–304
Hindsen M, Christensen OB (1992) Delayed hypersensitivity reactions following allergic and irritant inflammation. Acta Derm Venereol 72:220–221
Gawkrodger DJ, McVittie E, Hunter JA (1987) Immunophenotyping of the eczematous flare-up reaction in a nickel-sensitive subject. Dermatology 175:171–177
Polak L, Turk JL (1968) Studies on the effect of systemic administration of sensitizers in guinea-pigs with contact sensitivity to inorganic metal compounds.II. The flare-up of previous test sites of contact sensitivity and the development of a generalized rash. Clin Exp Immunol 3:253–262
Moser B, Loetscher M, Piali L, Loetscher P (1998) Lymphocyte responses to chemokines. Int Rev Immunol 16:323–3244
Rustemeyer T, de Groot J, von Blomberg BME, Frosch PJ, Scheper RJ (2002) Assessment of contact allergen cross-reactivity by retesting. Exp Dermatol 11:257–265
Matura M (1998) Contact allergy to locally applied corticosteroids. Thesis, Leuven, Belgium
Inerot A, Moller H (2000) Symptoms and signs reported during patch testing. Am J Contact Dermatol 11:49–52
Isaksson M, Bruze M (2003) Late patch-test reactions to budesonide need not be a sign of sensitization induced by the test procedure. Am J Contact Dermatol 14:154–156
Zinkernagel RM (2004) On “reactivity” versus “tolerance”. Immunol Cell Biol 82:343–352
Piccirillo CA, Thornton AM (2004) Cornerstone of peripheral tolerance: naturally occurring CD4+CD25+ regulatory T cells. Trends Immunol 25:374–380
Benson JM, Whitacre CC (1997) The role of clonal deletion and anergy in oral tolerance. Res Immunol 148:533–541
Ferber I, Schönrich G, Schenkel J, Mellor AL, Hämmerling GJ, Arnold B (1994) Levels of peripheral T cell tolerance induced by different doses of tolerogen. Science 263:674–676
Morgan DJ, Kreuwel HTC, Sherman LA (1999) Antigen concentration and precursor frequency determine the rate of CD8(+) T cell tolerance to peripherally expressed antigens. J Immunol 163:723–727
Shreedhar V, Giese T, Sung VW, Ullrich SE (1998) A cytokine cascade including prostaglandin E2, IL-4, and IL-10 is responsible for UV-induced systemic immune suppression. J Immunol 160:3783–3789
Semma M, Sagami S (1981) Induction of suppressor T cells to DNFB contact sensitivity by application of sensitizer through Langerhans cell-deficient skin. Arch Dermatol Res 271:361–364
Taams LS, van Eden W, Wauben MHM (1999) Dose-dependent induction of distinct anergic phenotypes: multiple levels of T cell anergy. J Immunol 162:1974–1981
Girolomoni G, Gisondi P, Ottaviani C, Cavani A (2004) Immunoregulation of allergic contact dermatitis. J Dermatol 31:264–270
Mayer L, Sperber K, Chan L, Child J, Toy L (2001) Oral tolerance to protein antigens. Allergy 56:12–15
Weiner HL, Gonnella PA, Slavin A, Maron R (1997) Oral tolerance: cytokine milieu in the gut and modulation of tolerance by cytokines. Res Immunol 148:528–533
Wang YH, Liu YJ (2008) The IL-17 cytokine family and their role in allergic inflammation. Curr Opin Immunol 20(6):697–702
Rustemeyer T, de Groot J, von Blomberg BME, Frosch PJ, Scheper RJ (2001) Induction of tolerance and cross-tolerance to methacrylate contact sensitizers. Toxicol Appl Pharmacol 176:195–202
Miller SD, Sy M-S, Claman HN (1977) The induction of hapten-specific T cell tolerance using hapten-modified lymphoid membranes. II. Relative roles of suppressor T cells and clone inhibition in the tolerant state. Eur J Immunol 7:165–170
Polak L (1980) Immunological aspects of contact sensitivity. An experimental study. Monogr Allergy 15:4–60
Weiner HL (1997) Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol Today 18:335–343
Weigle WO, Romball CG (1997) CD4+ T-cell subsets and cytokines involved in peripheral tolerance. Immunol Today 18:533–538
Arnaboldi PM, Roth-Walter F, Mayer L (2009) Suppression of Th1 and Th17, but not Th2, responses in a CD8(+) T cell-mediated model of oral tolerance. Mucosal Immunol 2(5):427–438
Zembala M, Ashershon GL (1973) Depression of T cell phenomenon of contact sensitivity by T cells from unresponsive mice. Nature 244:227–228
Boerrigter GH, Scheper RJ (1984) Local administration of the cytostatic drug 4-hydroperoxy-cyclophosphamde (4-HPCY) facilitates cell mediated immune reactions. Clin Exp Immunol 58:161–166
Boerrigter GH, de Groot J, Scheper RJ (1986) Intradermal administration of 4-hydoperoxy-cyclophosphamde during contact sensitization potentiates effector T cell responsiveness in draining lymph nodes. Immunopharmacology 1:13–20
Mokyr MB, Kalinichenko T, Gorelik L, Bluestone JA (1998) Realization of the therapeutic potential of CTLA-4 blockade in low-dose chemotherapy-treated tumor-bearing mice. Cancer Res 58:5301–5304
Knop J, Stremmer R, Neumann C, Dc Maeyer D, Macher E (1982) Interferon inhibits the suppressor T cell response of delayed-type hypersensitivity. Nature 296:775–776
Zhang ZY, Michael JG (1990) Orally inducible immune unresponsiveness is abrogated by IFN-gamma treatment. J Immunol 144:4163–4165
Claessen AME, von Blomberg BME, de Groot J, Wolvers DAE, Kraal G, Scheper RJ (1996) Reversal of mucosal tolerance by subcutaneous administration of interleukin-12 at the site of attempted sensitization. Immunology 88:363–367
Bridoux F, Badou A, Saoudi A, Bernard L, Druet E, Pasquier R, Druet P, Pelletier L (1997) Transforming growth factor beta (TGF-beta)-dependent inhibition of T helper cell 2 (Th2)-induced autoimmunity by self-major histocompatibility complex (MHC) class II-specific, regulatory CD4+ T cell lines. J Exp Med 185:1769–1775
Cavani A, Nasorri F, Ottaviani C, Sebastiani S, De Pita O, Girolomoni G (2003) Human CD25+ regulatory T cells maintain immune tolerance to nickel in healthy, nonallergic individuals. J Immunol 171:5760–5768
Hafler DA, Kent SC, Pietrusewicz MJ, Khoury SJ, Weiner HL, Fukaura H (1997) Oral administration of myelin induces antigen-specific TGF-beta 1 secreting T cells in patients with multiple sclerosis. Ann N Y Acad Sci 835:120–131
Lonati A, Licenziati S, Marcelli M, Canaris D, Pasolini G, Caruso A, de Panfilis G (1998) Quantitative analysis “at the single cell level” of the novel CD28-CD11b- subpopulation of CD8+ T lymphocytes. ESDR meeting at Cologne
De Panfilis G (1998) CD8+ cytolytic T lymphocytes and the skin. Exp Dermatol 7:121–131
Ilan Y (2009) Oral tolerance: can we make it work? Hum Immunol 70(10):768–776
Kuchroo VK, Byrne MC, Atsumi Y, Greenfeld E, Connol JH, Whitters MJ, O’Hara RM, Collins M, Dorf ME (1991) T cell receptor alpha chain plays a critical role in antigen-specific suppressor cell function. Proc Natl Acad Sci U S A 88:8700–8704
Taams LS, Boot EPJ, van Eden W, Wauben MHM (2000) “Anergic” T cells modulate the T-cell activating capacity of antigen-presenting cells. J Autoimmun 14:335–341
Taams LS, van Rensen AJML, Poelen MC, van Els CACM, Besseling AC, Wagenaar JPA, van Eden W, Wauben MHM (1998) Anergic T cells actively suppress T cell responses via the antigen presenting cell. Eur J Immunol 28:2902–2912
Kalinski P, Schuitemaker JH, Hilkens CM, Kapsenberg ML (1998) Prostaglandin E2 induces the final maturation of IL-12 deficient CD1a+CD83+ dendritic cells. J Immunol 161:2804–2809
Steinbrink K, Wolf M, Jonuleit H, Knop J, Enk AH (1997) Induction of tolerance by IL-10-treated dendritic cells. J Immunol 159:4772–4780
Steinbrink K, Jonuleit H, Muller G, Schuler G, Knop J, Enk AH (1999) Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. Blood 93:1634–1642
Van Hoogstraten IMW, Andersen JE, von Blomberg BME, Boden D, Bruynzeel DP, Burrows D, Camarasa JMG, Dooms-Goossens A, Lahti A, Menné T, Rycroft R, Todd D, Vreeburg KJJ, Wilkinson JD, Scheper RJ (1989) Preliminary results of a multicenter study on the incidence of nickel allergy in relationship to previous oral and cutaneous contacts. In: Frosch PJ, Dooms-Goossens A, Lachapelle JM, Rycroft RJG, Scheper RJ (eds) Current topics in contact dermatitis. Springer, Berlin, pp 178–184
Strobel S, Mowat AM (1998) Immune responses to dietary antigens: oral tolerance. Immunol Today 19:173–181
von Herrath MG (1997) Bystander suppression induced by oral tolerance. Res Immunol 148:541–554
Fowler E, Weiner HL (1997) Oral tolerance: elucidation of mechanisms and application to treatment of autoimmune diseases. Biopolymers 43:323–335
Van Hoogstraten IMW, von Blomberg BME, Boden D, Kraal G, Scheper RJ (1994) Non-sensitizing epicutaneous skin tests prevent subsequent induction of immune tolerance. J Invest Dermatol 102:80–83
Epstein WL (1987) The poison ivy picker of Pennypack Park: the continuing saga of poison ivy. J Invest Dermatol 88:7–9
Morris DL (1998) Intradermal testing and sublingual in desensitization for nickel. Cutis 61:129–132
Wendel GD, Stark BJ, Jamison RB, Molina RD, Sullivan TJ (1985) Penicillin allergy and desensitization in serious infections during pregnancy. N Engl J Med 312: 1229–1232
Panzani RC, Schiavino D, Nucera E, Pellegrino S, Fais G, Schinco G, Patriarca G (1995) Oral hyposensitization to nickel allergy: preliminary clinical results. Int Arch Allergy Immunol 107:251–254
Troost RJ, Kozel MM, van Helden-Meeuwsen CG, van Joost T, Mulder PG, Benner R, Prens EP (1995) Hyposensitization in nickel allergic contact dermatitis: clinical and immunologic monitoring. J Am Acad Dermatol 32:576–583
Chase MW (1946) Inhibition of experimental drug allergy by prior feeding of the sensitizing agent. Proc Soc Exp Biol Med 61:257–259
Polak L, Turk SL (1968) Studies on the effect of systemic administration of sensitizers in guinea pigs with contact sensitivity to inorganic metal compounds. I. The induction of immunological unresponsiveness in already sensitized animals. Clin Exp Immunol 3:245–251
Polak L, Rinck C (1978) Mechanism of desensitization in DNCH-contact sensitive guinea pigs. J Invest Dermatol 70:98–104
Gaspari AA, Jenkins MK, Katz SI (1988) Class II MCH-bearing keratinocytes induce antigen-specific unresponsiveness in hapten-specific TH1 clones. J Immunol 141:2216–2220
Murphy K, Travers P, Walport M (eds) (2008) Janeway’s immunobiology, 7th edn. Garland Science, Taylor & Francis Group, US, UK
Gaga M, Ong YE, Benyahia F, Aizen M, Barkans J (2008) Kay AB.Skin reactivity and local cell recruitment in human atopic and nonatopic subjects by CCL2/MCP-1 and CCL3/MIP-1alpha. Allergy 63(6):703–711
Homey B, Alenius H, Müller A, Soto H, Bowman EP, Yuan W, McEvoy L, Lauerma AI, Assmann T, Bünemann E, Lehto M, Wolff H, Yen D, Marxhausen H, To W, Sedgwick J, Ruzicka T, Lehmann P, Zlotnik A (2002) CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 8(2):157–165
Kagami S, Saeki H, Tsunemi Y, Nakamura K, Kuwano Y, Komine M, Nakayama T, Yoshie O, Tamaki K (2008) CCL27-transgenic mice show enhanced contact hypersensitivity to Th2, but not Th1 stimuli. Eur J Immunol 38(3):647–657
Grimm MC, Ng WS (2008) Road most traveled: gut-specific migration signals and leucocyte entry to the intestine. J Gastroenterol Hepatol 23(12):1775
Gomez J, Gonzalez A, Martinez-A C, Rebollo A (1998) IL-2-induced cellular events. Crit Rev Immunol 18:185–220
Berridge MJ (1997) Lymphocyte activation in health and disease. Crit Rev Immunol 17:155–178
Theze J, Alzari PM, Bertoglio J (1996) Interleukin 2 and its receptors: recent advances and new immunological functions. Immunol Today 17:481–486
Lacour M, Arrighi J-F, Müller KM, Carlberg C, Saurat J-H, Hauser C (1994) cAMP up-regulates IL-4 and IL-5 production from activated CD4+ T cells while decreasing IL-2 release and NF-AT induction. Int Immunol 6:1333–1343
Linsley PS, Ledbetter JA (1993) The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 11:191–212
Mazzoni A, Segal DM (2004) Controlling the Toll road to dendritic cell polarization. J Leukoc Biol 75:721–730
O’Garra A (1998) Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8:275–283
Santana MA, Rosenstein Y (2003) What it takes to become an effector T cell: the process, the cells involved, and the mechanisms. J Cell Physiol 195:392–401
Burkett PR, Koka R, Chien M, Boone DL, Ma A (2004) Generation, maintenance, and function of memory T cells. Adv Immunol 83:191–231
Spahn TW, Kucharzik T (2004) Modulating the intestinal immune system: the role of lymphotoxin and GALT organs. Gut 53:456–465
Bour H, Peyron E, Gaucherand M, Garrigue JL, Desvignes C, Kaiserlian D, Revillard JP, Nicolas JF (1995) Major histocompatibility complex class I-restricted CD8+ T cells and class II-restricted CD4+ T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene. Eur J Immunol 25:3006–3010
Paul WE, Ohara J (1987) B-cell stimulatory factor-1/interleukin 4. Annu Rev Immunol 5:429–459
Mackey MF, Barth RJ, Noelle RJ (1998) The role of CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cell. J Leuk Biol 63:418–428
Kuchroo V, Prabhu Das M, Brown JA, Ranger A, Zamvill MSS, Sobel RA, Weiner HL, Nabavi N, Glimcher LH (1995) B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways. Application to autoimmune disease therapy. Cell 80: 707–718
Ranger AM, Prabhu Das M, Kuchroo VK, Glimcher LH (1996) B7–2 (CD86) is essential for the development of IL-4 producing cells. Int Immunol 153:1549–1560
Schweitzer AN, Borriello F, Wong RCK, Abbas AK, Sharpe AH (1997) Role of costimulators in T cell differentiation – studies using antigen-presenting cells lacking expression of CD80 or CD86. J Immunol 158:2713–2722
Rulifson IC, Sperling AI, Fields PE, Fitch FW, Bluestone JA (1997) CD28 costimulation promotes the production of Th2 cytokines. J Immunol 158:658–665
Pernis A, Gupta S, Gollob KJ, Garfein E, Coffman RL, Schindler C, Rothman P (1995) Lack of interferon gamma receptor beta chain and the prevention of interferon signaling in Th1 cells. Science 269:245–247
Yoshimoto T, Takeda K, Tanaka T, Ohkusu K, Kashiwamura S, Okamura H, Akira S, Nakanishi K (1998) IL-12 up-regulates IL-18 receptor expression on T cells, TH1 cells, and B cells – synergism with IL-18 for IFN-gamma production. J Immunol 161:3400–3407
Zanni MP, Mauri-Hellweg D, Brander C, Wendland T, Schnyder B, Frei E, von Greyerz S, Bircher A, Pichler WJ (1997) Characterization of lidocaine-specific T cells. J Immunol 158:1139–1148
Rincon M, Anguita J, Nakamura T, Fikrig E, Flavell RA (1997) Interleukin (IL)-6 directs the differentiation of IL-4 producing CD4+ T cells. J Exp Med 182:1591–1596
Yoshimoto T, Bendelac A, Watson C, Hu-Li J, Paul WE (1995) Role of NK1.1+ T cells in a TH2 response and in immunoglobulin E production. Science 270:1845–1847
Hiroi T, Iwatani K, Iijima H, Kodama S, Yanagita M, Kiyono H (1998) Nasal immune system – distinctive Th0 and Th1/Th2 type environments in murine nasal-associated lymphoid tissues and nasal passage, respectively. Eur J Immunol 28:3346–3353
Banchereau J (1995) Converging and diverging properties of human interleukin-4 and interleukin-10. Behr Inst Mitteil 96:58–77
Itoh K, Hirohata S (1995) The role of IL-10 in human B cell activation, proliferation, and differentiation. J Immunol 154:4341–4350
Napolitano LM, Buzdon MM, Shi HJ, Bass BL (1997) Intestinal epithelial cell regulation cell regulation of macrophage and lymphocyte interleukin 10 expression. Arch Surg 132:1271–1276
Xu H, Banerjee A, Diulio NA, Fairchild RL (1996) T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (IL)-4/IL-10-producing (Th2) negative regulatory CD4+ T cells. J Exp Med 183: 1001–1012
Letterio JL, Roberts AB (1998) Regulation of immune responses by TGF-beta. Annu Rev Immunol 16:137–161
Hosken NA, Shibuya K, Heath AW, Murphy KM, O’Garra A (1995) The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor phenotype development in a T cell receptor alpha/beta-transgenic model. J Exp Med 182:1579–1584
Scholzen T, Armstrong CA, Bunnett NW, Luger TA, Olerud JE, Ansel JC (1998) Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems. Exp Dermatol 7:81–96
Westerman J, Geismar U, Sponholz A, Bode U, Sparshott BEB (1997) CD4+ T cells of both the naive and the memory phenotype enter rat lymph nodes and Peyer’s patches via high endothelial venules: within the tissue their migratory behaviour differs. Eur J Immunol 27:3174–3181
Marshall D, Haskard DO (2002) Clinical overview of leukocyte adhesion and migration: where are we now? Semin Immunol 14:133–140
Hall JG, Morris B (1965) The origin of cells in the efferent lymph from a single lymph node. J Exp Med 121:901–910
Hwang ST (2001) Mechanisms of T-cell homing to skin. Adv Dermatol 17:211–241
Pober JS, Kluger MS, Schechner JS (2001) Human endothelial cell presentation of antigen and the homing of memory/effector T cells to skin. Ann N Y Acad Sci 941:12–25
Mackay CR (1993) Homing of naïve, memory and effector lymphocytes. Curr Opin Immunol 5:423–427
Tietz W, Allemand Y, Borges E, Vonlaer D, Hallmann R, Vestweber D, Hamann A (1998) CD4(+) T cells migrate into inflamed skin only if they express ligands for E- and P-selectin. J Immunol 16:963–970
Rosen Homey B (2004) Chemokines and chemokine receptors as targets in the therapy of psoriasis. Curr Drug Targets Inflamm Allergy 3:169–174
Homey B, Bunemann E (2004) Chemokines and inflammatory skin diseases. Ernst Schering Res Found Workshop 4:69–83
Tanchot C, Rocha B (1998) The organization of mature T-cell pools. Immunol Today 19:575–579
Williams IR (2004) Chemokine receptors and leukocyte trafficking in the mucosal immune system. Immunol Res 29:283–292
Telemo E, Korotkova M, Hanson LA (2003) Antigen presentation and processing in the intestinal mucosa and lymphocyte homing. Ann Allergy Asthma Immunol 90:28–33
Picker LJ, Treer JR, Ferguson-Darnell B, Collins PA, Bergstresser PR, Terstappen LWMM (1993) Control of lymphocyte recirculation in man: II. Differential regulation of the cutaneous lymphocyte associated antigen, a tissue-selective homing receptor for skin homing T cells. J Immunol 150:1122–1136
Sunderkötter C, Steinbrink K, Henseleit U, Bosse R, Schwarz A, Vestweber D, Sorg C (1996) Activated T cells induce expression of E-selectin in vitro and in an antigen-dependent manner in vivo. Eur J Immunol 26:1571–1579
Tensen CP, Flier J, Rampersad SS, Sampat-Sardjoerpersad A, Scheper RJ, Boorsma DM, Willemze R (1999) Genomic organization, sequence and transcriptional regulation of the human CXCL 11 gene. Biochim Biophys Acta 1446:167–172
Sallusto F, Kremmer E, Palermo B, Hoy A, Ponath P, Qin SX, Forster R, Lipp M, Lanzavecchia A (1999) Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells. Eur J Immunol 29:2037–2045
Baggiolini M (1998) Chemokines and leukocyte traffic. Nature 392:565–568
Bell EB, Sparshott SM, Bunce C (1998) CD4+ T-cell memory, CD45R subsets and the persistence of antigen – a unifying concept. Immunol Today 19:60–64
Bell EB, Sparshott SM, Ager A (1995) Migration pathways of CD4 T cell subsets in vivo: the CD45RC- subset enters the thymus via alpha 4 integrin- VCAM-1 interaction. Int Immunol 11:1861–1871
Stoof TJ, Boorsma DM, Nickoloff BJ (1994) Keratinocytes and immunological cytokines. In: Leigh I, Lane B, Watt F (eds) The keratinocyte handbook. Cambridge University Press, Cambridge, pp 365–399
Tensen CP, Flier J, van der Raaij-Helmer EM, Sampat-Sardjoepersad S, van den Schors RC, Leurs R, Scheper RJ, Boorsma DM, Willemze R (1999) Human IP-9: a keratinocyte derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3). J Invest Dermatol 112:716–722
Virag L, Szabo E, Bakondi E, Bai P, Gergely P, Hunyadi J, Szabo C (2002) Nitric oxide-peroxynitrite-poly(ADP-ribose) polymerase pathway in the skin. Exp Dermatol 11:189–202
Ptak W, Askenase PW, Rosenstein RW, Gershon RK (1982) Transfer of an antigen-specific immediate hypersensitivity-like reaction with an antigen-binding factor produced by T cells. Proc Natl Acad Sci U S A 79:1969–1973
Van Loveren H, Ratzlaff RE, Kato K, Meade R, Ferguson TA, Iverson GM, Janeway CA, Askenase PW (1986) Immune serum from mice contact-sensitized with picryl chloride contains an antigen-specific T cell factor that transfers immediate cutaneous reactivity. Eur J Immunol 16:1203–1208
Ptak W, Herzog WR, Askenase PW (1991) Delayed-type hypersensitivity initiation by early-acting cells that are antigen mismatched or MHC incompatible with late-acting, delayed-type hypersensitivity effector T cells. J Immunol 146:469–475
Askenase PW, Kawikova I, Paliwal V, Akahira-Azuma M, Gerard C, Hugli T, Tsuji R (1999) A new paradigm of T cell allergy: requirement for the B-1 B cell subset. Int Arch All Appl Immunol 118:145–149
Hardy RR, Hayakawa K (1994) CD5+ B cells, a fetal B cell lineage. Adv Immunol 55:297–339
Feinstein A, Richardson N, Taussig MJ (1986) Immunoglobulin flexibility in complement activation. Immunol Today 7:169–173
Geba GP, Ptak W, Anderson GA, Ratzlaff RE, Levin J, Askenase PW (1996) Delayed-type hypersensitivity in mast cell deficient mice: dependence on platelets for expression on contact sensitivity. J Immunol 157:557–565
Salerno A, Dieli F (1998) Role of gamma delta T lymphocytes in immune response in humans and mice. Crit Rev Immunol 18:327–357
Szczepanik M, Lewis J, Geba GP, Ptak W, Askenase PW (1998) Positive regulatory gamma-delta T cells in contact sensitivity – augmented responses by in vivo treatment with anti-gamma-delta monoclonal antibody, or anti-V-gamma-5 or V-delta-4. Immunol Invest 27:1–15
Tang HL, Cyster JG (1999) Chemokine up-regulation and activated T cell attraction by maturing dendritic cells. Science 284:819–822
Vana G, Meingassner JG (2000) Morphologic and immunohistochemical features of experimentally induced allergic contact dermatitis in Gottingen minipigs. Vet Pathol 37:565–580
Teraki Y, Picker LJ (1997) Independent regulation of cutaneous lymphocyte-associated antigen expression and cytokine synthesis phenotype during human CD4+ memory T cell differentiation. J Immunol 159:6018–6029
Butcher EC, Picker LJ (1996) Lymphocyte homing and homeostasis. Science 272:60–66
Strunk D, Egger C, Leitner G, Hanau D, Stingl G (1997) A skin homing molecule defines the Langerhans cell progenitor in human peripheral blood. J Exp Med 185:1131–1136
Wroblewski M, Hamann A (1997) CD45-mediated signals can trigger shedding of lymphocyte L-selectin. Int Immunol 9:555–562
Burastero SE, Rossi GA, Crimi E (1998) Selective differences in the expression of the homing receptors of helper lymphocyte subsets. Clin Immunol Immunopathol 89:110–116
Wahbi A, Marcusson JA, Sundqvist KG (1996) Expression of adhesion molecules and their ligands in contact allergy. Exp Dermatol 5:12–19
Dailey MO (1998) Expression of T lymphocyte adhesion molecules: regulation during antigen-induced T cell activation and differentiation. Crit Rev Immunol 18:153–184
Oppenheimer-Marks N, Lipsky PE (1997) Migration of naïve and memory T cells. Immunol Today 18:456–457
Romanic AM, Graesser D, Baron JL, Visintin I, Janeway CA Jr, Madri JA (1997) T cell adhesion to endothelial cells and extracellular matrix is modulated upon transendothelial cell migration. Lab Invest 76:11–23
Zanni MP, von Greyerz S, Schnyder B, Brander KA, Frutig K, Hari Y, Valitutti S, Pichler WJ (1998) HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human alpha beta T lymphocytes. J Clin Invest 102:1591–1598
Akdis CA, Akdis M, Simon HU, Blaser K (1999) Regulation of allergic inflammation by skin-homing T cells in allergic eczema. Int Arch Allergy Immunol 118:140–144
Okazaki F, Kanzaki H, Fujii K, Arata J, Akiba H, Tsujii K, Iwatsuki K (2002) Initial recruitment of interferon-gamma-producing CD8+ effector cells, followed by infiltration of CD4+ cells in 2, 4, 6-trinitro-1-chlorobenzene (TNCB)-induced murine contact hypersensitivity reactions. J Dermatol 29:699–708
Pichler WJ, Schnyder B, Zanni MP, Hari Y, von Greyerz S (1998) Role of T cells in drug allergies. Allergy 53:225–232
Kehren J, Desvignes C, Krasteva M, Ducluzeau MT, Assossou O, Horand F, Hahne M, Kagi D, Kaiserlian D, Nicolas JF (1999) Cytotoxicity is mandatory for CD8+ T cell mediated contact hypersensitivity. J Exp Med 189:779–786
Mauri-Hellweg D, Bettens F, Mauri D, Brander C, Hunziker T, Pichler WJ (1995) Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine. J Immunol 155:462–472
Stark GR, Kerr IM, Williams BRG, Silverman RH, Schreiber RD (1998) How cells respond to interferons. Annu Rev Biochem 67:227–264
Yamada H, Matsukura M, Yudate T, Chihara J, Stingl G, Tezuka T (1997) Enhanced production of RANTES, an eosinophil chemoattractant factor, by cytokine-stimulated epidermal keratinocytes. Int Arch Aller Immunol 114:28–32
Siveke JT, Hamann A (1998) T helper 1 and T helper 2 Cells respond differentially to chemokines. J Immunol 160:550–554
Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M, Koch AE, Moser B, Mackay CR (1998) The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 101:746–754
Rocha B, von Boehmer H (1991) Peripheral selection of the T cell repertoire. Science 251:1225–1228
Arnold B, Schönrich G, Hämmerling GJ (1993) Multiple levels of peripheral tolerance. Immunol Today 14:12–14
Pozzilli P, Gisella Cavallo M (2000) Oral insulin and the induction of tolerance in man: reality or fantasy? Diabetes Metab Res Rev 16:306–307
Röcken M, Shevach EM (1996) Immune deviation – the third dimension of nondeletional T cell tolerance. Immunol Rev 149:175–194
Kumar V, Sercarz E (1998) Induction or protection from experimental autoimmune encephalomyelitis depends on the cytokine secretion profile of TCR peptide-specific regulatory CD4 T cells. J Immunol 161:6585–6591
Strober W, Kelsall B, Marth T (1998) Oral tolerance. J Clin Immunol 18:1–30
Inobe J, Slavin AJ, Komagata Y, Chen Y, Liu L, Weiner HL (1998) IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis. Eur J Immunol 28:2780–2790
Allan SE, Broady R, Gregori S, Himmel ME, Locke N, Roncarolo MG, Bacchetta R, Levings MK (2008) CD4+ T-regulatory cells: toward therapy for human diseases. Immunol Rev 223:391–421
Croft M, So T, Duan W, Soroosh P (2009) The significance of OX40 and OX40L to T-cell biology and immune disease. Immunol Rev 229(1):173–191
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Rustemeyer, T., van Hoogstraten, I.M.W., von Blomberg, B.M.E., Gibbs, S., Scheper, R.J. (2011). Mechanisms of Irritant and Allergic Contact Dermatitis. In: Johansen, J., Frosch, P., Lepoittevin, JP. (eds) Contact Dermatitis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-03827-3_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-03827-3_3
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-03826-6
Online ISBN: 978-3-642-03827-3
eBook Packages: MedicineMedicine (R0)